All In Biotech

Drug Trial Radar · NCT07093814

A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

42

Planned (sponsor's estimate)

Start

Sep 2, 2025

Primary completion

Dec 31, 2028

Study completion Jun 30, 2029

Sponsor

Sponsor type
Industry
First posted
Jul 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is an open-label, single-arm Phase I/II clinical trial with the primary objective of evaluating the safety, tolerability, and efficacy of VRT106 in patients with recurrent/progressive glioblastoma.

Conditions

  • Glioblastoma

Interventions

  • VRT106Drug

    VRT106,intravenous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the safety and tolerability of escalating doses of VRT106 in Patients with recurrent/progressive glioblastomaTime frame: About 2 years

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of USTC

    Hefei, Anhui, China · Not yet recruiting

  • Sanbo Brain Hospital Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The Cancer Hospital Affiliated to Chongqing University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China · Recruiting

  • Shenzhen Second People's Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The Fifth Affiliated Hospital of Sun Yat-sen University

    Zhuhai, Guangdong, China · Recruiting

  • Guangxi Medical University Cancer Hospital

    Nanning, Guangxi, China · Recruiting

  • Qilu Hospital of Shandong University

    Jinan, Shandong, China · Not yet recruiting

  • Tangdu Hospital of Air Force Medical University of the PLA

    Xi’an, Shanxi, China · Not yet recruiting

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.